Eileen Gu's  Instablog

Eileen Gu
Send Message
I have been working in market/Industry research for almost 5 years since I got my Master's Degree of Management. I used to be an analyst for 3 years and turned to customer oriented position in recent years. I hope we can build a knowledge sharing networks to exchange information and values.... More
My company:
China Research and Intelligence
My blog:
  • Cri-report Market Size Of In Vitro Diagnostics To Be USD 24.1 Billion In 2016 0 comments
    Jun 26, 2012 10:19 PM

    (CRI-report) - In-vitro diagnostics is a diagnostics method through detecting samples (blood, body fluid, tissues, etc.) taken out from human bodies so as to judge diseases and functions of organisms. In most cases, the detection system composed of detection instruments and reagents are applied in in-vitro diagnostics.

    In-vitro diagnostic reagents are used to carry out in-vitro detection for human samples. In Chinese market, there are mainly three categories, biochemical diagnostic reagents, immune diagnostic reagents and molecule diagnostic reagents, accounting for over 60% of the market share of in-vitro diagnostic reagents in total in 2011.

    The global in-vitro diagnostics market is mature and the concentration rate is high. Major 8 enterprises account for over 70% of the market share. In 2011, the market scale of global in-vitro diagnostics was as high as USD 44 billion, among which Europe, the United States, Japan and other developed countries accounted for 87%. Emerging economic entities accounted for few proportions, while its growth rate was far ahead of mature markets.

    In China, market access barriers of this industry are not high and the concentration is low. The majority of enterprises concentrate in the biochemical reagent field and synthetic enterprises are few, the competition is mainly in bio-chemical field therefore. Both the supply and demand of immune and molecule products are prosperous. In addition to immune reagents, markets of other diagnostic reagents are mainly occupied by Chinese domestic enterprises. Although Chinese in-vitro diagnostic reagent industry starts late, it has the rapid growth rate. In 2011, the market scale has reached CNY 11.5 billion, among which immune diagnostic reagents accounted for 33%, as well as biochemical diagnostic reagents and molecular diagnostic reagents separately accounted for 27% and 5%.

    According to the investigation of CRI Report, the productivity utilization of China's major in-vitro diagnostic reagent manufacturers is universally high. As a result, it is predicted that the productivity of the industry will expanse in the future. Furthermore, the development strategy of most enterprises is transversely enriching product varieties and vertically developing towards the upper and downstream integration.

    China's population accounts for more than 20% of the world's population, while the market share of in-vitro diagnostics is less than 5% of the world; in 2011, the annual consumption per capita of China's in-vitro diagnostic products was less than USD 2, while that of developed countries reached USD 25 to USD 30. As a consequent, there is a wide increase space for China's in-vitro diagnostics. It is predicted that during 2012 and 2016, the growth rate of the market scale of China's in-vitro diagnostics will be markedly higher than the global average level and the annual compound growth rate will maintain over 15%, according to Research Report on China's In-vitro Diagnostic Reagent Industry, 2012. By 2016, the market scale will achieve USD 24.1 billion, among which immune and biochemical products will continually occupy the main market share, while the proportion of molecular products will relatively increase. During the upgrading and updating of products in the future and the process of domestic substitution, the industry concentration rate will be intensified.

    More following information can be acquired through Research Report on China's In-vitro Diagnostic Reagent Industry, 2012:

    -Development Course and Current Situation of China's In-vitro Diagnostic Reagent Industry

    -Government Policies Faced by China's In-vitro Diagnostic Reagent Industry

    -Market Competition of In-vitro Diagnostic Reagent Industry

    - China's Major Manufacturers of In-vitro Diagnostic Reagents

    -Prediction on Development of In-vitro Diagnostic Reagent Industry

    Following people are recommended to buy Research Report on China's In-vitro Diagnostic Reagent Industry, 2012:

    -Manufacturers of In-vitro Diagnostic Reagents

    -Trade Enterprises of In-vitro Diagnostic Reagents

    -Investors and Research Institutions Focusing on In-vitro Diagnostic Reagent Industry

    Get the full report: www.cri-report.com/diagnostics/2697-rese...

Back To Eileen Gu's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.